Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Gives $5.4M for Ontario Cancer Research Project

NEW YORK (GenomeWeb News) – Pfizer Global Research and Development will collaborate with two Ontario institutes to discover and validate targets that could be used to diagnose, predict, or treat colorectal cancer.

Under the collaboration, Pfizer will invest C$6 million ($5.4 million) in a partnership with the Ontario Institute for Cancer Research (OICR) and the Ontario Cancer Institute (OCI) at the Princess Margaret Hospital (PMH). The Ontario Ministry of Research and Innovation also is investing C$900,000 in the Project, called PMH-OICR-Pfizer-CURE (POP-CURE), through the Biopharmaceutical Investment Program, which is part of Ontario's Next Generation Jobs Fund.

OICR and OCI will conduct genomics and molecular pathology studies and develop a large clinical biobank to identify molecular signatures that will be used to develop biomarkers for early detection, monitoring, and treatment of cancer.

The institutes also will use existing Ontario Government support to build related research infrastructure, such as equipment and tissue banks.

Ben Neel, who is director of OCI and is serving as a principal investigator on the project, said in a statement that the collaboration will "join the world class genomics and informatics programs at OICR, cutting edge research in cancer stem cell biology and functional genomics at OCI/PMH and the world's largest pharmaceutical company in a concerted effort to bring new therapies to colon cancer patients worldwide."

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.